News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Myles David C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2020 |
4
| Myles David C. (Chief Development Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 12,831 shares
@ $0
Converted 154,846 shares
@ $0
Converted 12,831 convertible preferred
@ $0
Converted 154,846 convertible preferred
@ $0 |
|
| 11/19/2020 |
4
| Myles David C. (Chief Development Officer) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 143,472 shares
@ $0
Granted 179,340 options to buy
@ $19, valued at
$3.4M
|
|
| 11/18/2020 |
3
| Myles David C. (Chief Development Officer) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
|
|